Imaging and diagnostic advances for intracranial meningiomas.
暂无分享,去创建一个
Raymond Y Huang | K. Aldape | P. Wen | M. Vogelbaum | T. Kaufmann | I. Dunn | G. Zadeh | B. Griffith | C. la Fougère | W. Bi | J. Tonn | F. Nassiri | N. Schmidt
[1] R. Fimmers,et al. Meningioma assessment: Kinetic parameters in dynamic contrast-enhanced MRI appear independent from microvascular anatomy and VEGF expression. , 2018, Journal of neuroradiology. Journal de neuroradiologie.
[2] U. Haberkorn,et al. Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy , 2018, Radiation oncology.
[3] Jacob S. Young,et al. Relationship between tumor location, size, and WHO grade in meningioma. , 2018, Neurosurgical focus.
[4] Chien-Feng Li,et al. Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value , 2018, Journal of Neuro-Oncology.
[5] S. Bernard,et al. Meningioma growth dynamics assessed by radiocarbon retrospective birth dating , 2017, EBioMedicine.
[6] A. Wienke,et al. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin , 2015, Oncotarget.
[7] Danny J. J. Wang,et al. Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas. , 2017, European journal of radiology.
[8] M. Weller,et al. PET imaging in patients with meningioma—report of the RANO/PET Group , 2017, Neuro-oncology.
[9] Raymond Y Huang,et al. Radiographic prediction of meningioma grade by semantic and radiomic features , 2017, PloS one.
[10] Jeong Hoon Kim,et al. "Wait-and-See" Strategies for Newly Diagnosed Intracranial Meningiomas Based on the Risk of Future Observation Failure. , 2017, World neurosurgery.
[11] J. Engh,et al. Alteration of the Ki-67 Proliferative Index following Surgical Resection with or without Radiation Therapy of Intracranial Meningiomas , 2017, Cureus.
[12] S. Cha,et al. Meningioma mimics: five key imaging features to differentiate them from meningiomas. , 2017, Clinical radiology.
[13] A. Wienke,et al. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean , 2017, Oncotarget.
[14] T. Santarius,et al. Correlation of volumetric growth and histological grade in 50 meningiomas , 2017, Acta Neurochirurgica.
[15] Hongyang Zhao,et al. The Potential Value of Preoperative MRI Texture and Shape Analysis in Grading Meningiomas: A Preliminary Investigation , 2017, Translational oncology.
[16] W. Paiva,et al. Clinical Outcome, Tumor Recurrence, and Causes of Death: A Long-Term Follow-Up of Surgically Treated Meningiomas. , 2017, World neurosurgery.
[17] M. Reiser,et al. Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI , 2017, The Journal of Nuclear Medicine.
[18] M. Cherian,et al. Comparison of post-contrast 3D-T1-MPRAGE, 3D-T1-SPACE and 3D-T2-FLAIR MR images in evaluation of meningeal abnormalities at 3-T MRI. , 2017, The British journal of radiology.
[19] Armando Manduca,et al. Slip interface imaging based on MR‐elastography preoperatively predicts meningioma–brain adhesion , 2017, Journal of magnetic resonance imaging : JMRI.
[20] Young-Hoon Kim,et al. A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. , 2017, Journal of neurosurgery.
[21] A. Nanda,et al. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. , 2017, Journal of neurosurgery.
[22] Se Hoon Kim,et al. Amide proton transfer imaging for differentiation of benign and atypical meningiomas , 2017, European Radiology.
[23] T. Santarius,et al. Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review , 2017, Acta Neurochirurgica.
[24] R. Jain,et al. Perfusion Imaging in Neuro-Oncology: Basic Techniques and Clinical Applications. , 2016, Magnetic resonance imaging clinics of North America.
[25] K. Wei,et al. Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas , 2016, Scientific Reports.
[26] M. Weller,et al. EANO guidelines for the diagnosis and treatment of meningiomas. , 2016, The Lancet. Oncology.
[27] A. Buck,et al. 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? , 2016, Neuro-oncology.
[28] Z. Cho,et al. Experience with 7.0 T MRI in Patients with Supratentorial Meningiomas , 2016, Journal of Korean Neurosurgical Society.
[29] J. Hainsworth,et al. A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma , 2016, Journal of Neuro-Oncology.
[30] J. Farah,et al. Early adjuvant radiotherapy in the treatment of atypical meningioma , 2016, Journal of Clinical Neuroscience.
[31] T. Huber,et al. Patterns and Time Dependence of Unspecific Enhancement in Postoperative Magnetic Resonance Imaging After Glioblastoma Resection. , 2016, World neurosurgery.
[32] T. Jiang,et al. Correlations of magnetic resonance, perfusion-weighed imaging parameters and microvessel density in meningioma. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[33] Jörg-Christian Tonn,et al. Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography. , 2016, Journal of neurosurgery.
[34] M. Weller,et al. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. , 2016, Neuro-oncology.
[35] O. Boyko,et al. Predicting Meningioma Consistency on Preoperative Neuroimaging Studies. , 2016, Neurosurgery clinics of North America.
[36] Thomas C Chen. Primary Intraosseous Meningioma. , 2016, Neurosurgery clinics of North America.
[37] M. Shiroishi,et al. Advanced Imaging of Intracranial Meningiomas. , 2016, Neurosurgery clinics of North America.
[38] M. Weller,et al. Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. , 2016, Neuro-oncology.
[39] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[40] A. Niemierko,et al. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. , 2015, Neuro-oncology.
[41] K. Aldape,et al. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. , 2016, Journal of neurosurgery.
[42] T. Mathiesen. The quality of articles and challenges ahead , 2016, Acta Neurochirurgica.
[43] U. Roelcke,et al. Susceptibility changes in meningiomas influence the apparent diffusion coefficient in diffusion-weighted MRI. , 2015, Journal of neuroradiology. Journal de neuroradiologie.
[44] A. Wienke,et al. Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters12 , 2015, Translational oncology.
[45] Richard Ehman,et al. Higher-Resolution Magnetic Resonance Elastography in Meningiomas to Determine Intratumoral Consistency. , 2015, Neurosurgery.
[46] S. Mukundan,et al. Utility of dynamic computed tomography angiography in the preoperative evaluation of skull base tumors. , 2015, Journal of neurosurgery.
[47] R. Tarnawski,et al. The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report. , 2015, Current radiopharmaceuticals.
[48] Jun Pan,et al. Preoperative Radiologic Classification of Convexity Meningioma to Predict the Survival and Aggressive Meningioma Behavior , 2015, PloS one.
[49] U. Schüller,et al. Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue , 2015, The Journal of Nuclear Medicine.
[50] M. Briel,et al. Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial , 2015, The Journal of Nuclear Medicine.
[51] M. Kataoka,et al. Grading Meningioma , 2015, Medicine.
[52] A. Haug,et al. Ga-68-DOTA-TATE PET/CT for Discrimination of Tumors of the Optic Pathway , 2015, Orbit.
[53] Jill S. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.
[54] H. Sakahara,et al. Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas , 2015, Journal of Neuro-Oncology.
[55] M. Feychting,et al. Long-term follow-up of incidentally discovered meningiomas , 2015, Acta Neurochirurgica.
[56] E. Hattingen,et al. Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. , 2014, Neurosurgical focus.
[57] R. Prayson,et al. Dural-based Rosai–Dorfman disease: Differential diagnostic considerations , 2014, Journal of Clinical Neuroscience.
[58] Hung-Wen Kao,et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. , 2014, Journal of neurosurgery.
[59] Shin Jung,et al. Immunohistochemical profile of the dural tail in intracranial meningiomas , 2014, Acta Neurochirurgica.
[60] Y. Mao,et al. Diffusion tensor magnetic resonance imaging for predicting the consistency of intracranial meningiomas , 2014, Acta Neurochirurgica.
[61] D. Takhtani,et al. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma. , 2014, AJR. American journal of roentgenology.
[62] Jian-Rong Xu,et al. Usefulness of Dual-Energy Computed Tomography Imaging in the Differential Diagnosis of Sellar Meningiomas and Pituitary Adenomas: Preliminary Report , 2014, PloS one.
[63] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[64] K. Langen,et al. 68Ga-DOTATATE-positron emission tomography imaging in spinal meningioma , 2014, Journal of craniovertebral junction & spine.
[65] F. Yamasaki,et al. Preoperative histological grading of meningiomas using apparent diffusion coefficient at 3T MRI. , 2013, European journal of radiology.
[66] Armando Manduca,et al. Preoperative assessment of meningioma stiffness using magnetic resonance elastography. , 2013, Journal of neurosurgery.
[67] Feng-ping Huang,et al. Histopathological classification and location of consecutively operated meningiomas at a single institution in China from 2001 to 2010. , 2013, Chinese medical journal.
[68] I. Steffen,et al. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. , 2013, International journal of radiation oncology, biology, physics.
[69] B. Yin,et al. Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. , 2012, European journal of radiology.
[70] Figen Soylemezoglu,et al. Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas? , 2012, European journal of radiology.
[71] P. Schaefer,et al. Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas. , 2012, Academic radiology.
[72] U. Haberkorn,et al. Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[73] R. McLendon,et al. Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series , 2012, Journal of Neuro-Oncology.
[74] R. Sweeney,et al. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[75] H. Kishima,et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. , 2012, Journal of Neurosurgery.
[76] Mitsutoshi Nakada,et al. Prediction of high-grade meningioma by preoperative MRI assessment , 2012, Journal of Neuro-Oncology.
[77] John Y. K. Lee,et al. Determination of grade and subtype of meningiomas by using histogram analysis of diffusion-tensor imaging metrics. , 2012, Radiology.
[78] R. Jain,et al. Computer-aided volumetric analysis as a sensitive tool for the management of incidental meningiomas , 2012, Acta Neurochirurgica.
[79] I. Tsougos,et al. Distinct peak at 3.8 ppm observed by 3T MR spectroscopy in meningiomas, while nearly absent in high-grade gliomas and cerebral metastases , 2012, Molecular medicine reports.
[80] T. Watabe,et al. Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography , 2012, Journal of Neuro-Oncology.
[81] Fredric B. Meyer,et al. Use of preoperative magnetic resonance imaging T1 and T2 sequences to determine intraoperative meningioma consistency , 2011, Surgical neurology international.
[82] J. Tonn,et al. Molecular imaging of gliomas with PET: opportunities and limitations. , 2011, Neuro-oncology.
[83] Matthias Briel,et al. Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] S. Oya,et al. The natural history of intracranial meningiomas. , 2011, Journal of neurosurgery.
[85] M. Berger,et al. Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article. , 2011, Journal of neurosurgery.
[86] J. Liu. Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas , 2011 .
[87] J. Jito,et al. Growth curve analysis of asymptomatic and symptomatic meningiomas , 2011, Journal of Neuro-Oncology.
[88] D. Ginat,et al. Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. , 2010, AJR. American journal of roentgenology.
[89] M. McDermott,et al. Treatment decision making based on the published natural history and growth rate of small meningiomas. , 2010, Journal of neurosurgery.
[90] T. Huisman. Diffusion-weighted and diffusion tensor imaging of the brain, made easy , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.
[91] D. Long,et al. Perioperative and Long-term Outcomes From the Management of Parasagittal Meningiomas Invading the Superior Sagittal Sinus , 2010, Neurosurgery.
[92] R. Scienza,et al. Diffusion-weighted imaging does not predict histological grading in meningiomas , 2010, Acta Neurochirurgica.
[93] C. Belka,et al. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning , 2009, Radiation oncology.
[94] Ting-Yim Lee,et al. Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 2: Technical Implementations , 2009, American Journal of Neuroradiology.
[95] Jeong Won Lee,et al. 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[96] Naoki Kagawa,et al. Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. , 2009, Journal of neurosurgery.
[97] M. Cremonesi,et al. Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[98] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[99] S. Ng,et al. Differentiation Between Classic and Atypical Meningiomas with Use of Diffusion Tensor Imaging , 2008, American Journal of Neuroradiology.
[100] C. Lim,et al. DIFFUSION TENSOR TRACTOGRAPHY: CORTICOSPINAL TRACT FIBER REDUCTION IS ASSOCIATED WITH TEMPORARY HEMIPARESIS IN BENIGN EXTRACEREBRAL LESIONS , 2008, Neurosurgery.
[101] Y.H. Chan,et al. Diffusion-Weighted MR Imaging: Diagnosing Atypical or Malignant Meningiomas and Detecting Tumor Dedifferentiation , 2008, American Journal of Neuroradiology.
[102] E. Krenning,et al. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] W. Joo,et al. Peritumoral brain edema in meningiomas: correlations between magnetic resonance imaging, angiography, and pathology. , 2008, Surgical neurology.
[104] Matthijs Oudkerk,et al. Perfusion MR imaging for differentiation of benign and malignant meningiomas , 2008, Neuroradiology.
[105] M. Radoš,et al. Characteristics of typical and atypical meningiomas on ADC maps with respect to schwannomas. , 2008, Clinical imaging.
[106] C. Alafaci,et al. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? , 2008, Oncology reports.
[107] R. Mrak,et al. Management of bone-invasive, hyperostotic sphenoid wing meningiomas. , 2007, Journal of neurosurgery.
[108] W M Adams,et al. Atypical imaging appearances of intracranial meningiomas. , 2007, Clinical radiology.
[109] H. Chang,et al. FDG PET/CT Assessment of the Biological Behavior of Meningiomas , 2006 .
[110] A. Dinçer,et al. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. , 2006, European journal of radiology.
[111] T. Hori,et al. Clinical and radiological features related to the growth potential of meningioma , 2006, Neurosurgical Review.
[112] Bahattin Hakyemez,et al. Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? , 2006, Neuroradiology.
[113] B. Hakyemez,et al. The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas , 2006, Neuroradiology.
[114] T. Yoshimine,et al. Scoring radiologic characteristics to predict proliferative potential in meningiomas , 2006, Brain Tumor Pathology.
[115] H. Itoh,et al. Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. , 2006, AJNR. American journal of neuroradiology.
[116] Kaoru Kurisu,et al. Apparent diffusion coefficient of human brain tumors at MR imaging. , 2005, Radiology.
[117] S. Nakasu,et al. Growth Pattern Changes of Meningiomas: Long-term Analysis , 2005, Neurosurgery.
[118] M. Samii,et al. Volumetric Analysis of the Growth Rate of Incompletely Resected Intracranial Meningiomas , 2005, Zentralblatt fur Neurochirurgie.
[119] Glyn Johnson,et al. Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. , 2003, AJNR. American journal of neuroradiology.
[120] Madjid Samii,et al. The Natural History of Incidental Meningiomas , 2003, Neurosurgery.
[121] Glyn Johnson,et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.
[122] W. Wong,et al. Positron emission tomography (PET)--evaluation of 'indeterminate pulmonary lesions'. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).
[123] Jia-Hong Gao,et al. Perfusion MRI Evaluation of Correlating Perfusion Constants with Histologic Findings in Meningiomas , 2002 .
[124] T. Tamiya,et al. Peritumoral Brain Edema in Intracranial Meningiomas: Effects of Radiological and Histological Factors , 2001, Neurosurgery.
[125] M A Edgar,et al. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. , 2001, AJNR. American journal of neuroradiology.
[126] G. Fuller,et al. Primary extradural meningiomas: a report on nine cases and review of the literature from the era of computerized tomography scanning. , 2000, Journal of neurosurgery.
[127] Y. Iwadate,et al. Glucose and methionine uptake and proliferative activity in meningiomas. , 1999, Neurological research.
[128] K. Sugiyama,et al. Peritumoral brain edema associated with meningioma , 1999, Cancer.
[129] 吉岡 宏幸. Peritumoral brain edema in associated with meningioma : Influence of vascular endothelial growth factor expression and vascular blood supply , 1999 .
[130] U. Kumar,et al. Expression of somatostatin receptor subtypes in human brain tumors , 1998, International journal of cancer.
[131] B. Scheithauer,et al. Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.
[132] J. Gilsbach,et al. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[133] S. Nakasu,et al. Meningioma: proliferating potential and clinicoradiological features. , 1995, Neurosurgery.
[134] G. Hounsfield. Computerized transverse axial scanning (tomography): Part I. Description of system. 1973. , 1973, The British journal of radiology.
[135] K. Sartor,et al. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1995, Neurosurgery.
[136] A. Mahmood,et al. Atypical and malignant meningiomas: a clinicopathological review. , 1993 .
[137] S. Howng,et al. Intracranial meningioma. , 1992, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.
[138] A. Osborn,et al. Intracranial meningioma. , 1992, AJNR. American journal of neuroradiology.
[139] J. Smirniotopoulos,et al. Typical, atypical, and misleading features in meningioma. , 1991, Radiographics : a review publication of the Radiological Society of North America, Inc.
[140] S. Aoki,et al. Contrast-enhanced MR images in patients with meningioma: importance of enhancement of the dura adjacent to the tumor. , 1990, AJNR. American journal of neuroradiology.
[141] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[142] K. Go,et al. Peritumoral brain edema associated with meningiomas. , 1988, Neurosurgery.
[143] G. di Chiro,et al. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.
[144] J. Jääskeläinen,et al. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. , 1985, Surgical Neurology.
[145] H. Nakagawa,et al. Multiple meningiomas evaluated by computed tomography. , 1981, Neurosurgery.
[146] A. George,et al. Atypical computed tomography features of intracranial meningioma: radiological-pathological correlation in a series of 131 consecutive cases. , 1980, Radiology.
[147] P. Lauterbur,et al. Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.
[148] D. Simpson. THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENT , 1957, Journal of neurology, neurosurgery, and psychiatry.
[149] F. Hodges,et al. Differential diagnosis of intracranial neoplasms by cerebral angiography. , 1947, Radiology.